Related Experiment Video
Updated: Jul 16, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
An Increase in Mucin2 Expression Is Required for Colon Cancer Progression Mediated by L1
Arka Saha1, Nancy Gavert1, Thomas Brabletz2
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
L1 cell adhesion molecule (L1CAM) induces Mucin2 in colon cancer, promoting tumor growth and metastasis. Suppressing Mucin2 inhibits cancer progression, suggesting Mucin2 as a therapeutic target for mucinous colon cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Wnt/β-catenin pathway activation in colon cancer upregulates L1 cell adhesion molecule (L1CAM).
- L1CAM is a Wnt target gene characteristic of advanced colon cancer.
- The role of secreted proteins following L1CAM induction in colon cancer progression is not fully understood.
Purpose of the Study:
- To investigate proteins secreted by L1CAM-expressing colon cancer cells.
- To determine the role of Mucin2 in L1CAM-driven colon cancer progression.
- To explore Mucin2 as a potential diagnostic marker and therapeutic target.
Main Methods:
- Analysis of proteins secreted by L1CAM-expressing colon cancer cells.
- Functional assays to assess the impact of Mucin2 suppression on colon cancer cell behavior (proliferation, motility, tumorigenesis, metastasis).
- Analysis of Mucin2 expression in human colon cancer tissues (adenocarcinoma vs. mucinous subtype) and correlation with patient survival.
Main Results:
- Mucin2 was identified as a highly abundant secreted protein in L1CAM-expressing colon cancer cells.
- Suppression of Mucin2 significantly inhibited colon cancer cell proliferation, motility, tumorigenesis, and liver metastasis.
- Mucin2 expression was reduced in adenocarcinoma but increased in mucinous colon cancer subtypes.
- Increased L1CAM/Mucin2 expression correlated with reduced patient survival.
Conclusions:
- L1CAM-induced Mucin2 expression is crucial for mucinous colon cancer progression.
- Mucin2 can serve as a diagnostic marker for colon cancer subtypes.
- Mucin2 represents a potential therapeutic target for colon cancer treatment.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
06:31Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
Related Concept Videos
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Renewal of Intestinal Stem Cells
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...